Morbus Anderson-Fabry
Strain reduction in ≥1 Segment also without myocardial wall thickening
Inferolateral (basal, medial) and anterolateral strain reduction
GLS reduction ➜ progress
Improvement of LASr ➜ successful therapy (GLS does not change)
DD & restrictive filling
Mitochondrial disease
Athlete's heart
Normal Dispersion –30 msec
Low-normal EF – here 50%
Borderline dimensions of the cardiac chambers in endurance exercise
-Endurance athletes (at least >4h/week)
-Not one single chamber affected
-All chambers show similar degree of dimension change
